Skip to content

Robot-assisted Training

Evaluation of a Portable Isokinetic Knee Training Device for Quadriceps Rehabilitation in Children With SMA

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06648486
Enrollment
13
Registered
2024-10-18
Start date
2025-02-25
Completion date
2025-08-30
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Muscular Atrophy (SMA)

Brief summary

The goal of this clinical trial is to evaluate the long-term effects of isokinetic rehabilitation training in patients with spinal muscular atrophy (SMA). The main question it aims to answer is: • Does isokinetic training at fixed angular velocity improve muscle strength and functional recovery in SMA patients? Participants will: * Perform isokinetic training using a portable device with a fixed angular velocity. * Undergo long-term rehabilitation sessions, with assessments of muscle strength and overall functional improvement over the training period.

Interventions

DEVICEWith the assistance of wearable isokinetic training robot ( 7 children with SMA type II)

A child with SMA will use a wearable isokinetic training robot to train the knee joint for three stages. ( Stage 1: 1.5 months=30 sessions; Stage 2 (follow up): 1.5 months=18 sessions, Stage 3(follow up) = 0 session)

Sponsors

Peking University Third Hospital
Lead SponsorOTHER
Beihang University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Masking description

7 Children with SMA, 6 Healthy Children as comparison

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

1. Age range: 6-12 years old. 2. Diagnosed with Type II Spinal Muscular Atrophy (SMA).

Exclusion criteria

1. Participants with severe comorbidities, implanted medical devices preventing MRI or claustrophobia were excluded from the study. 2. Refusal to provide informed consent or inability to complete the entire study protocol, among other factors; 3. Uncontrolled hypertension (systolic blood pressure ≥160 mmHg and/or diastolic blood pressure ≥95 mmHg) or congestive heart failure classified as New York Heart Association (NYHA) Class III or IV; 4. Cognitively impaired or unable to comprehend the requirements of study participation.

Design outcomes

Primary

MeasureTime frameDescription
Change in cross sectional area of quadricepsBaseline, after 1.5 months, after 3 months and after 4 monthsUsing Magnetic Resonance Imaging (MRI)
Change in longitudinal cross-sectional width of quadricepsBaseline, after 1.5 months, after 3 months and after 4 monthsUsing Magnetic Resonance Imaging (MRI)
Change in peak torqueBaseline, after 1.5 months, after 3 months and after 4 monthsUsing isokinetic training robot to measure.
Change in average torqueBaseline, after 1.5 months, after 3 months and after 4 monthsUsing isokinetic training robot to measure.
Change in work of kneeBaseline, after 1.5 months, after 3 months and after 4 monthsWork = Torque \* Speed
Change in Surface Electromyography (sEMG)Baseline, after 1.5 months, after 3 months and after 4 months
Change in Nerve conductionBaseline, after 1.5 months, after 3 months and after 4 monthsNerve Conduction Velocity Testing System

Secondary

MeasureTime frame
Change in weightBaseline, after 1.5 months, after 3 months and after 4 months
Change in heightBaseline, after 1.5 months, after 3 months and after 4 months
Change in joint angleBaseline, after 1.5 months, after 3 months and after 4 months

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026